Industry Roundup: Restoring Access Legislation, Adulterated Ayurvedics, UK Claims Enforcement
This article was originally published in The Tan Sheet
Mylan, Perrigo more candid in hostile takeover comments; House committee clears Restoring Access bill; UK enforces on supplement ad claims.
You may also be interested in...
CHPA is optimistic 2015 is the year “common sense” will restore OTC eligibility for health spending accounts. Speaking on the group’s priorities, President and CEO Scott Melville said CHPA will work to improve the OTC monograph system and to curb cough medicine abuse.
The Conservative Party's victory in the UK general election means the Brexit withdrawal deal will be able to pass. The UK will leave the EU by 31 January and enter a transition period during which medicines regulation will remain broadly unchanged.
Japanese companies agree to discontinue regenerative cell therapy pact after high-profile Phase II failure, but SanBio will move ahead with development and Dainippon will hold onto ex-partner stake for now.